AbbVie (ABBV) EPS (Diluted) (2012 - 2026)
AbbVie's EPS (Diluted) came in at $2.38 for Q3 2026, compared with $0.10 a year earlier and up 16.7% from the prior quarter.
Powered by 
Analysis
AbbVie (ABBV) EPS (Diluted) (2012 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, AbbVie reported EPS (Diluted) of $5.84, up 333.1% year-over-year.
- EPS (Diluted) has declined in each of the last three years, with a five-year compound annual growth rate of -2.9% (FY2020 to FY2025).
- Going back by year, EPS (Diluted) was $2.41 in FY2024 (-12.0%), $2.74 in FY2023 (-58.8%), $6.66 in FY2022 (+2.5%) and $6.50 in FY2021 (+135.4%).
- The Q3 2026 figure represents the highest quarterly EPS (Diluted) since Q1 2022.
- Year-over-year, EPS (Diluted) increased in 1 of the last five quarters, with growth averaging 22.7%.
- The fastest year-over-year change in EPS (Diluted) over five years came in Q1 2024 (growth of 473.8%), and the weakest in Q1 2023 (a decline of 94.7%).
- Business Quant data shows ABBV's EPS (Diluted) at $2.04 (Q2 2026), $0.39 (Q1 2026) and $1.02 (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 7.22 |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 0.09 |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 2.38 |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 2.04 |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 1.67 |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 1.60 |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 7.08 |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 1.94 |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 0.56 |
| 10 | Vertex Pharmaceuticals | 138.78 Bn | 110.77 Bn | 2.91 Bn | 2.56 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 2.38 |
| Jun 30, 2026 | 2.04 |
| Mar 31, 2026 | 0.39 |
| Dec 31, 2025 | 1.02 |
| Sep 30, 2025 | 0.10 |
| Jun 30, 2025 | 0.53 |
| Mar 31, 2025 | 0.73 |
| Dec 31, 2024 | -0.01 |
| Sep 30, 2024 | 0.88 |
| Jun 30, 2024 | 0.77 |
| Mar 31, 2024 | 0.77 |
| Dec 31, 2023 | 0.46 |
| Sep 30, 2023 | 1.00 |
| Jun 30, 2023 | 1.14 |
| Mar 31, 2023 | 0.13 |
| Dec 31, 2022 | 1.39 |
| Sep 30, 2022 | 2.22 |
| Jun 30, 2022 | 0.52 |
| Mar 31, 2022 | 2.53 |
| Dec 31, 2021 | 2.28 |
API Access
AbbVie EPS (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=eps-diluted&ticker=ABBV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "eps-diluted", "ticker": "ABBV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=eps-diluted&ticker=ABBV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();